STATUTE: DRUG1101 (3 F)
NOTES: JD/FUENTE 100406
STATUTE: DRUG8100 (1 M)
NOTES: JD/FUENTE 100406
STATUTE: COPS2060 (1 M)
NOTES: JD/FUENTE 100406
STATUTE: DRUG1101 (3 F)
NOTES: FTA A/O 091306 KLR7538
STATUTE: DRUG9101 (3 F)
NOTES: JD/FUENTE 100406
STATUTE: DRUG9881 (2 M)
NOTES: FTA A/O 091306 KLR7538
STATUTE: DRUG8100 (1 M)
NOTES: JD/FUENTE 100406
STATUTE: DRUG1101 (3 F)
NOTES: VOP CT 1
STATUTE: DRUG9101 (3 F)
NOTES: J.PERRY 062408
STATUTE: DRUG1101 (3 F)
NOTES: VOP CT 2
STATUTE: DRUG9101 (3 F)
NOTES: PC VOP
STATUTE: DRUG1101 (3 F)
NOTES: J/PERRY 111507
STATUTE: DRUG1101 (3 F)
NOTES: PC VOP
STATUTE: DRUG1101 (3 F)
NOTES: VOP CT 1
STATUTE: DRUG9101 (3 F)
NOTES: J/PERRY 041207
STATUTE: DRUG1101 (3 F)
NOTES: VOP CT 2
STATUTE: DRUG9881 (2 M)
NOTES: (INDOMETHACIN)
STATUTE: DRUG9101 (3 F)
NOTES: JD/STODDARD 041206
STATUTE: DRUG1101 (3 F)
NOTES: SCHD IV FEL 3 (XANAX)
STATUTE: DRUG8100 (1 M)
NOTES: JD/STODDARD 041206
STATUTE: TRES1000 (2 M)
BOND: $500
NOTES: FTA